InsiderClue
← All stocks

Lexaria Bioscience Corp.

LEXX Net buying
CIK 0001348362 #5058 in the set updated 21 Sep 2026
Bought (120 mo)
$219.40K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$105.27K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$105.27K
4 of 4 sales
Net
+$114.13K
+$114.13K against sales at will

By person

10 insiders · 34 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
CHRISTOPHER RICHARD
Chief Executive Officer
$132.03K (3)
—
+$132.03K
65,000
$59.35K
—
McKechnie William Edward
Director
$4.53K (1)
$95.00K (3)
−$90.47K
18,191
$16.61K
—
BUNKA CHRISTOPHER
Director
$67.89K (16)
—
+$67.89K
7,226,754
$6.60M
+16.7%
Carle Vanessa
Secretary
$682.50 (1)
$10.27K (1)
−$9.59K
750
$684.83
+1,019%
TURKEL CATHERINE C.
Director
$9.27K (2)
—
+$9.27K
3,100
$2.83K
—
DOCHERTY JOHN MARTIN
President & CSO
$4.99K (1)
—
+$4.99K
59,451
$54.28K
—
Spissinger Allan Horst
Chief Financial Officer
—
—
—
119,116
$108.76K
+333.9%
Baxter Nicholas W
Director
—
—
—
11,000
$10.04K
—
REESE ALBERT L JR
Director
—
—
—
10,917
$9.97K
+1,091%
Downey Gregory
Chief Financial Officer
—
—
—
1,954
$1.78K
+6.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Carle Vanessa
14 May 2024
Secretary
Exercised, kept
2,500
$1.15
$2.88K
McKechnie William Edward
23 Jul 2020
Director
Exercised, kept
110,000
$0.17
$19.03K
Baxter Nicholas W
20 Dec 2019
Director
Exercised, kept
110,000
$0.10
$11.00K
Spissinger Allan Horst
15 Feb 2019
Chief Financial Officer
Exercised, kept
50,000
$0.37
$18.50K
BUNKA CHRISTOPHER
18 Jun 2018
CEO
Exercised, kept
247,500
$0.09
$22.28K
BUNKA CHRISTOPHER
18 Jun 2018
CEO
Exercised, kept indirect
450,000
$0.14
$63.00K
Show all 34 transactions →

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,346,455
Sales filed before the plan box existed 3
History held since 6 Oct 2016